Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Multicenter Observational Study of Urine-Based BladMetrix Monitoring for Recurrence in Non-Muscle Invasive Bladder Cancer

NCT07511517 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT07511517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Multicenter Observational Study of Urine-Based BladMetrix Monitoring for Recurrence in Non-Muscle Invasive Bladder Cancer
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
October 3, 2019
Completion date
June 30, 2027
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, transitional cell, bladder, non-muscle invasive bladder neoplasms, urinary bladder neoplasms